Published in Blood Weekly, May 25th, 2006
CD133 is a genetic expression marker for presence of developing endothelial cells in the peripheral blood circulation and is associated with angiogenesis, the growth of new capillary blood vessels. Clinical research from several academic centers in Europe and the U.S. has shown that CD133 is a promising prognostic indicator of tumor growth.
"New research suggests that the CD133 biomarker...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.